Clinical Scorecard: A Randomized-Controlled Study Comparing Skills-Based Virtual Reality, Distraction Virtual Reality, and Sham Virtual Reality for Managing Chronic Low Back Pain
At a Glance
Category
Detail
Condition
Chronic low back pain (cLBP)
Key Mechanisms
Virtual Reality interventions including Skills-Based VR (biofeedback, interoceptive training, relaxation), Distraction VR (immersive 360-degree videos), and Sham VR (2D videos)
Target Population
Adults with chronic low back pain
Care Setting
Home-based, non-pharmacological therapy
Key Highlights
No significant difference between active VR (Skills-Based and Distraction) and Sham VR on primary outcome (PROMIS Pain Interference) or most secondary outcomes.
Distraction VR group showed greater reduction in daily opioid use compared to Sham VR (p = 0.009).
Baseline anxiety predicted improvement in pain interference within the Skills-Based VR group (p = 0.025); depression symptoms did not.
Guideline-Based Recommendations
Diagnosis
Use PROMIS Pain Interference (PI) to assess pain impact in chronic low back pain.
Management
Consider home-based VR interventions as feasible adjunct therapies for cLBP.
Distraction VR may help reduce opioid use in cLBP patients.
Skills-Based VR may benefit patients with higher baseline anxiety.
Monitoring & Follow-up
Monitor opioid use changes during VR therapy.
Assess for adverse events such as mild cybersickness.
Track adherence to home-based VR interventions.
Risks
Adverse events are generally mild and self-limited; cybersickness is the most common.
No evidence of superiority of active VR over sham VR for pain interference reduction.
Patient & Prescribing Data
Community-based adults with chronic low back pain
Distraction VR demonstrated a statistically significant reduction in daily opioid use compared to sham VR; high adherence supports feasibility of home-based VR therapies.
Clinical Best Practices
Incorporate VR as a non-pharmacological adjunct for managing chronic low back pain, especially for patients seeking home-based options.
Evaluate baseline anxiety to identify patients who may benefit more from Skills-Based VR.
Educate patients about potential mild side effects such as cybersickness and monitor accordingly.
Use PROMIS Pain Interference scores to assess treatment response.
Consider opioid use reduction as an important outcome in future VR-based interventions.
by Brennan M. R. Spiegel, Samuel A. Eberlein, Susan Persky, Mariko L. Ishimori, Swamy Venuturupalli, Joseph Tu, Fadi Alhatem, Mary A. Vijjeswarapu, Zoe Krut, Tom Norris, So Yung Choi, Mourad Tighiouart, Lindsey Ross, Mark Vrahas, Omer Liran, Itai Danovitch, Tinh Vuong, Joshua Fouladian
In a target-trial emulation of more than 600,000 veterans, GLP-1 RA initiators saw fewer new substance use disorders—and patients with existing SUDs had fewer overdoses, hospitalizations, and deaths.
